Personalized Risk Assessment of Colorectal Cancer Based on Natural Anti-Cancer Defense Mechanisms: A Potential Tool for Prevention and Early Detection
Grant Amount: NIS 4.9 Million
About the Project
The team plans to develop markers for personal risk assessment of colorectal cancer, one of the most common and deadliest cancer types. The markers will be based on our body’s natural defenses against cancer, and will include DNA repair, suicide of pre-cancerous cells, and our immune system. These markers and the risk assessment will be used for prevention and early detection of colorectal cancer, with the goal of reducing its incidence and mortality.
Research Team
Prof. Zvi Livneh
Weizmann Institute of Science (Biomolecular Sciences)
Prof. Moshe Oren
Weizmann Institute of Science (Molecular Cell Biology)
Prof. Baruch Brenner
Rabin Medical Center – Beilinson Hospital (Davidoff Center for the Treatment and Research of Cancer)
Dr. Tamar Paz-Elizur
Weizmann Institute of Science (Biomolecular Sciences)
More Projects Funded